Back to search
FDAFDA · Food and drugs·Recall number D-1025-2018

Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-05.

Published August 8, 2018 · Recall initiated: July 24, 2018

Summary

FDA records drug Class II recall D-1025-2018, published August 8, 2018 and initiated July 24, 2018. Recalling firm: West-Ward Columbus Inc; Status: Terminated; Reported quantity: 29048 500-count bottles (14,524,000 tablets); Lot: Lot# 71545A, Expiry date: 07/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications:

What to do

Voluntary: Firm initiated

Get an email if DOXYCYCLINE HYCLATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DOXYCYCLINE HYCLATE
Manufacturer
West-Ward Columbus Inc
Distributor
Nationwide in the USA.
UPC
0301432112508
Lot
Lot# 71545A, Expiry date: 07/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-05. recalled?

Yes. FDA published recall D-1025-2018 on August 8, 2018. Reported hazard: Failed Dissolution Specifications:

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DOXYCYCLINE HYCLATE. UPC: 0301432112508.